Payer Almanac
About the data Sign in
Star measuresDisplay measuresHEDISWhy members leave

Measures · D14 in 2016 · Part D · DD4 Drug Safety and Accuracy of Drug Pricing

Medication Adherence for Cholesterol (Statins)

Drug PlanMedication AdherenceSource: Prescription Drug Events

What it measures
One of the most important ways you can manage your health is by taking your medication as directed. The plan, the doctor, and the member can work together to find ways to help the member take their medication as directed. Percent of plan members with a prescription for a cholesterol medication (a statin drug) who fill their prescription often enough to cover 80% or more of the time they are supposed to be taking the medication.
How it's calculated
This measure is defined as the percent of Medicare Part D beneficiaries 18 years and older that adhere to their prescribed drug therapy for statin cholesterol medications. This percentage is calculated as the number of member-years of enrolled beneficiaries 18 years and older with a proportion of days covered (PDC) at 80 percent or over for statin cholesterol medication(s) during the measurement period (numerator) divided by the number of member-years of enrolled beneficiaries 18 years and older with at least two fills of either the same medication or medication in the drug class during the measurement period (denominator). The PDC is the percent of days in the measurement period “covered” by prescription claims for the same medication or another in the therapeutic category. Beneficiaries are only included in the measure calculation if the first fill of their medication occurs at least 91 days before the end of the enrollment period. The Medication Adherence measure is adapted from the Medication Adherence- Proportion of Days Covered measure that was developed and endorsed by the Pharmacy Quality Alliance (PQA). The PDC Adherence measures are also endorsed by the National Quality Forum (NQF). See the medication list for this measure. The Medication Adherence rate is calculated using the National Drug Code (NDC) list and obsolete NDC date 2014 methodology maintained by the PQA. The complete NDC list will be posted along with these technical notes. For the 2015 Star Ratings, NDCs with obsolete dates will be included in the measure calculation if their obsolete dates as reported by PQA are within the period of measurement (measurement year) or within six months prior to the beginning of the measurement year.
Data source
Prescription Drug Event (PDE) data; Medicare Enrollment Database (EDB) File; The data for this measure come from PDE data files submitted by drug plans to Medicare for January 1, 2014-December 31, 2014 by June 30, 2015. Only final action PDE claims are used to calculate the patient safety measures. PDE claims are limited to members who received at least two prescriptions for a statin drug(s). PDE adjustments made post-reconciliation were not reflected in this measure.
Measurement period
01/01/2014 - 12/31/2014
Better when
Higher
Weight
3 (Intermediate Outcome Measure)
Star assignment
Clustering
Case-mix adjusted
—
In improvement measure
Yes
Used in CAI
—
Exclusions
ShowContracts with 30 or fewer enrolled member-years (in the denominator)
Notes
Part D drugs do not include drugs or classes of drugs, or their medical uses, which may be excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, except for smoking cessation agents. As such, these drugs, which may be included in the medication or NDC lists, are excluded from CMS analyses. Also, the member-years of adjustment adjustment is made by CMS to account for partial enrollment within the benefit year. Enrollment is measured at the spell level, and inclusion in the measure is determined separately for each spell – i.e., to be included for a given spell, the beneficiary must meet the initial inclusion criteria for the measure during that spell. The measure is weighted based on the total number of member years for each spell in which the beneficiary meets the measure criteria. For instance, if a beneficiary is enrolled for a three month spell, disenrolled for a six month spell, reenrolled for a three month spell, and meets the measure criteria during each enrollment spell, s/he will count as 0.5 member years in the rate calculation (3/12 + 3/12 = 6/12). The PDC calculation is adjusted for overlapping prescriptions for the same drug which is defined by active ingredient at the generic name level using the Medi-Span generic ingredient name. The calculation also adjusts for Part D beneficiaries’ stays in inpatient (IP) settings, hospice enrollments, and stays in skilled nursing facilities (SNFs). The SNF adjustment only applies to PDPs because SNF data are not currently available for MA- PDs. When available, beneficiary death date from the Common Medicare Environment (CME) is the end date of a beneficiary’s measurement period. Please see Attachment L: Medication Adherence Measure Calculations for more information about these calculations.

From the 2016 Star Ratings Technical Notes (CMS).

Cut points over time

Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.

How the 2028 cut points are projected

Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.

StarsOrg type2027Projected 2028Move
2★MA-PD8487+3
3★MA-PD8889+1
4★MA-PD9091+1
5★MA-PD9394+1
2★PDP8687+1
3★PDP8889+1
4★PDP9091+1
5★PDP93930

2016 star distribution

Not rated: Plan too new to be measured (102); No data available (30); Plan not required to report measure (12); Not enough data available (11)

Cut point bands

Star yearOrg type1★2★3★4★5★
2027MA-PD< 84 %>= 84 % to < 88 %>= 88 % to < 90 %>= 90 % to < 93 %>= 93 %
2027PDP< 86 %>= 86 % to < 88 %>= 88 % to < 90 %>= 90 % to < 93 %>= 93 %
2026MA-PD< 84 %>= 84 % to < 88 %>= 88 % to < 90 %>= 90 % to < 93 %>= 93 %
2026PDP< 87 %>= 87 % to < 89 %>= 89 % to < 90 %>= 90 % to < 92 %>= 92 %
2025MA-PD< 80 %>= 80 % to < 85 %>= 85 % to < 89 %>= 89 % to < 93 %>= 93 %
2025PDP< 86 %>= 86 % to < 88 %>= 88 % to < 89 %>= 89 % to < 92 %>= 92 %
2024MA-PD< 82 %>= 82 % to < 86 %>= 86 % to < 88 %>= 88 % to < 91 %>= 91 %
2024PDP< 84 %>= 84 % to < 87 %>= 87 % to < 89 %>= 89 % to < 93 %>= 93 %
2023MA-PD< 81 %>= 81 % to < 85 %>= 85 % to < 88 %>= 88 % to < 92 %>= 92 %
2023PDP< 84 %>= 84 % to < 87 %>= 87 % to < 88 %>= 88 % to < 90 %>= 90 %
2022MA-PD< 78 %>= 78 % to < 83 %>= 83 % to < 87 %>= 87 % to < 91 %>= 91 %
2022PDP< 82 %>= 82 % to < 86 %>= 86 % to < 88 %>= 88 % to < 90 %>= 90 %
2021MA-PD< 75 %>= 75 % to < 83 %>= 83 % to < 86 %>= 86 % to < 88 %>= 88 %
2021PDP< 78 %>= 78 % to < 81 %>= 81 % to < 86 %>= 86 % to < 88 %>= 88 %
2020MA-PD< 72%? 72% to < 80%? 80% to < 84%? 84% to < 87%? 87%
2020PDP< 79%? 79% to < 83%? 83% to < 86%? 86% to < 88%? 88%
2019MA-PD< 73%? 73% to < 77%? 77% to < 83%? 83% to < 87%? 87%
2019PDP< 80%? 80% to < 82%? 82% to < 84%? 84% to < 88%? 88%
2018MA-PD< 66%? 66% to < 76%? 76% to < 80%? 80% to < 85%? 85%
2018PDP< 73%? 73% to < 79%? 79% to < 82%? 82% to < 86%? 86%
2017MA-PD< 66%? 66% to < 73%? 73% to < 77%? 77% to < 82%? 82%
2017PDP< 70%? 70% to < 74%? 74% to < 80%? 80% to < 84%? 84%
2016MA-PD< 50%? 50% to < 61%? 61% to < 73%? 73% to < 79%? 79%
2016PDP< 68%? 68% to < 73%? 73% to < 78%? 78% to < 83%? 83%
2015MA-PD< 59%? 59% to < 68%? 68% to < 76%? 76% to < 83%? 83%
2015PDP< 62%? 62% to < 69%? 69% to < 75%? 75% to < 78%? 78%

Lowest-scoring contracts, 2016

ContractParentMembersScoreStarsΔShortfall to 4★Pctile
H8266 Constellation Health, Llc.Constellation Health, LLC.—211—520%
S2874 HumanaHumana Inc.—4910290%
H4011 MMM HEALTHCARE, LLC.InnovaCare Inc.—4210310%
H9915 Medstar Family Choice, Inc.Medstar Health, Inc.—502—230%
H4005 Triple-S AdvantageGuidewell Mutual Holding Corporation6,490522+1211%
H2029 HumanaHumana Inc.0532+1201%
H5577 MCS ClassicareMHH Healthcare, L.P.361,020542+1191%
H5774 Triple S AdvantageGuidewell Mutual Holding Corporation121,384552+1181%
H4003 Medicare y Mucho Mas (MMM)Elevance Health, Inc.94,108562+1172%
H4007 HumanaHumana Inc.—562+1172%
S2505 WINDSOR HEALTH PLAN, INC.WellCare Health Plans, Inc.—6820102%
H4004 Medicare y Mucho Mas (MMM)Elevance Health, Inc.101,304582+1152%
H9122 ALPHACARE OF NEW YORK, INC.Magellan Health, Inc.—582—152%
H4866 CUATRO LLCCuatro LLC.—592+1143%
H3054 Constellation Health, Llc.Constellation Health, LLC.—592—143%
H3337 LIBERTY HEALTH ADVANTAGE, INC.Liberty Health Advantage, Inc.—6020133%
H0913 WellcareCentene Corporation12,667613+2123%
H1903 WELLCARE OF LOUISIANA, INC.WellCare Health Plans, Inc.—613+1123%
H6623 MARICOPA COUNTY SPECIAL HEALTH CARE DISTRICTMARICOPA COUNTY SPECIAL HEALTH CARE DISTRICT—613—123%
S1140 Highmark Blue Cross Blue Shield or Highmark Blue ShieldHighmark Health3,185712−174%
S7694 Elixir InsuranceRite Aid Corporation—712074%
H9954 Anthem Insurance Companies, Inc.Anthem Inc.—623—114%
H1112 WellcareCentene Corporation25,885623+1114%
H5141 Clover HealthClover Health Holdings, Inc.156,154633+1104%
H8146 SECURITYCARE OF TENNESSEE, INC.BlueCross BlueShield of Tennessee—643—95%

History

Star yearCodeNameMeasuredWeightSource
2027D10Medication Adherence for Cholesterol (Statins)01/01/2025 – 12/31/20253Prescription Drug Events
2026D10Medication Adherence for Cholesterol (Statins)01/01/2024 – 12/31/20243Prescription Drug Events
2025D10Medication Adherence for Cholesterol (Statins)01/01/2023 – 12/31/20233Prescription Drug Events
2024D10Medication Adherence for Cholesterol (Statins)01/01/2022 – 12/31/20223Prescription Drug Events
2023D10Medication Adherence for Cholesterol (Statins)01/01/2021 – 12/31/20213Prescription Drug Events
2022D10Medication Adherence for Cholesterol (Statins)01/01/2020 – 12/31/20203Prescription Drug Events
2021D12Medication Adherence for Cholesterol (Statins)01/01/2019 – 12/31/20193Prescription Drug Events
2020D12Medication Adherence for Cholesterol (Statins)01/01/2018 – 12/31/20183Prescription Drug Events
2019D12Medication Adherence for Cholesterol (Statins)01/01/2017 – 12/31/20173Prescription Drug Events
2018D13Medication Adherence for Cholesterol (Statins)01/01/2016 – 12/31/20163Prescription Drug Events
2017D14Medication Adherence for Cholesterol (Statins)01/01/2015 - 12/31/20153Prescription Drug Events
2016D14Medication Adherence for Cholesterol (Statins)01/01/2014 - 12/31/20143Prescription Drug Events
2015D13Medication Adherence for Cholesterol (Statins)01/01/2013 - 12/31/20133Prescription Drug Events